Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

330.71
Delayed Data
As of 4:00pm ET
 +2.96 / +0.90%
Today’s Change
244.28
Today|||52-Week Range
348.84
+26.61%
Year-to-Date

Today’s Trading

Previous close327.75
Today’s open328.21
Day’s range327.25 - 332.85
Volume1,129,245
Average volume (3 months)1,253,374
Market cap$69.3B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+9.07%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+9.37%
P/E ratio20.3
Price/Sales6.09
Price/Book5.83

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+1.91+0.90%
GILDGilead Sciences+0.49+0.64%
----
BIVVBioverativ Inc-0.02-0.04%
Data as of 4:15pm ET, 12/13/2017

Financials

Next reporting dateJanuary 31, 2018
EPS forecast (this quarter)$5.54
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts